Drug Patent Expirations in October 2012

Drug Patent Expirations for October 2012

Tradename Applicant Generic Name Patent Number Patent Expiration
AZOPT Alcon Pharms Ltd brinzolamide 5,378,703*PED Oct 1, 2012
RAPAMUNE Wyeth Pharms Inc sirolimus 5,403,833*PED Oct 4, 2012
TRITEC Glaxosmithkline ranitidine bismuth citrate 5,456,925 Oct 10, 2012
ALOMIDE Alcon lodoxamide tromethamine 5,457,126 Oct 10, 2012
SPRIX Luitpold ketorolac tromethamine 7,476,689 Oct 11, 2012
ZEMPLAR Abbvie paricalcitol 5,246,925*PED Oct 17, 2012
OXANDRIN Savient Pharms oxandrolone 6,670,351 Oct 20, 2012
STARLIX Novartis nateglinide 5,463,116 Oct 21, 2012
CLARITIN-D 24 HOUR Schering Plough loratadine; pseudoephedrine sulfate 5,314,697 Oct 23, 2012
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.

Comments are closed.

Get email updates

Enter your email address to subscribe to this blog and receive notifications of new posts by email.